Jeffrey A. Bailey - 18 Aug 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Jeffrey A. Bailey
Issuer symbol
AUPH
Transactions as of
18 Aug 2023
Net transactions value
$0
Form type
4
Filing time
21 Aug 2023, 16:25:12 UTC
Previous filing
22 Mar 2022
Next filing
12 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Award $0 +17,913 $0.000000 17,913 18 Aug 2023 Common Stock 17,913 Direct F1
transaction AUPH Stock Option (right to buy) Award $0 +28,959 $0.000000 28,959 18 Aug 2023 Common Stock 28,959 $9.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024.
F2 The option vests in twelve equal monthly installments commencing on September 18, 2023.